Related Experiment Video
Updated: Jul 17, 2026
09:57
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Published on: June 4, 2017
Immunomodulatory neural stem cells for brain tumour therapy
Jeffrey J Yu1, Xiaonan Sun, Xiangpeng Yuan
1Cedars Sinai Medical Center, Department of Neurosurgery, Los Angeles, CA, USA. yuj@cshs.org
Expert Opinion on Biological Therapy
|January 17, 2007
Summary
Novel neural stem cell (NSC) therapies offer targeted brain tumor treatment by exploiting NSC migration. Preclinical research shows promise, but clinical application faces obstacles that require further investigation.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Oncology
Background:
- Neural stem cells (NSCs) exhibit inherent tropism for central nervous system (CNS) pathologies.
- Existing brain tumor treatments like surgery, radiation, and chemotherapy lack specificity.
- Advances in stem cell biology enable novel therapeutic strategies for brain tumors.
Purpose of the Study:
- To review preclinical advances in stem cell-based therapies for brain tumors.
- To discuss the potential of exploiting NSC tropism for targeted drug delivery.
- To identify obstacles to clinical development and propose solutions.
Main Methods:
- Review of preclinical studies on neural stem cell (NSC) therapies for brain tumors.
- Analysis of NSC migration and tropism in the context of CNS pathologies.
- Evaluation of immunomodulatory cytokine delivery via NSCs.
Main Results:
- NSC-based strategies demonstrate higher specificity compared to conventional treatments.
- Preclinical data support the effectiveness of stem cell therapies for brain tumors.
- Understanding NSC isolation and culturing is crucial for clinical translation.
Conclusions:
- Neural stem cell (NSC) therapies represent a promising, targeted approach for brain tumor treatment.
- Overcoming obstacles in clinical development is essential for realizing the potential of these novel therapies.
- Further research is needed to fully translate preclinical findings into clinical applications.
More Related Videos
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...